CHMP recommends EU approval for Roches TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of metastatic bladder cancer

24th July 2017 Uncategorised 0

Roche

More: CHMP recommends EU approval for Roches TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of metastatic bladder cancer
Source: MDlinx